Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-04-20 | Arthur J. Fratamico has served as a director of our Company since December of 2019. |
| 2021-04-15 | Arthur J. Fratamico has served as a director of our Company since December of 2019. He is a registered pharmacist with over 25 years of experience in the pharmaceutical industry and has been the Chief Business Officer at Galera Therapeutics, Inc., a biopharmaceutical company dedicated to discovering and developing novel dismutase mimetics with the goal of transforming cancer radiotherapy, since January 2017. |
| 2022-04-29 | Arthur J. Fratamico 56 Director |
| 2023-04-28 | Arthur J. Fratamico 57 Director ... The membership of each committee is as follows: ... Arthur J. Fratamico Member Compensation, Member Nominating and Governance ... Director Compensation The following table sets forth certain information regarding compensation of the persons who served as our non-employee directors during the most recent completed fiscal year. ... Arthur J. Fratamico 49,000 49,000 |
Data sourced from SEC filings. Last updated: 2026-03-05